DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/31e837/type_1_diabetes_j) has announced the addition of Global Markets Direct's new report "Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H1 2012" to their offering.
Global Markets Direct's, 'Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H1 2012', provides an overview of the Type 1 Diabetes (Juvenile Diabetes) therapeutic pipeline. This report provides information on the therapeutic development for Type 1 Diabetes (Juvenile Diabetes), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Type 1 Diabetes (Juvenile Diabetes). 'Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H1 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.
Key Topics Covered:
- Introduction
- Global Markets Direct Report Coverage
- Type 1 Diabetes (Juvenile Diabetes) Overview
- Therapeutics Development
- An Overview of Pipeline Products for Type 1 Diabetes (Juvenile Diabetes)
- Type 1 Diabetes (Juvenile Diabetes) Therapeutics under Development by Companies
- Type 1 Diabetes (Juvenile Diabetes) Therapeutics under Investigation by Universities/Institutes
- Late Stage Products
- Comparative Analysis
- Mid Clinical Stage Products
- Comparative Analysis
- Early Clinical Stage Products
- Comparative Analysis
- Discovery and Pre-Clinical Stage Products
- Comparative Analysis
- Type 1 Diabetes (Juvenile Diabetes) Therapeutics - Products under Development by Companies
- Type 1 Diabetes (Juvenile Diabetes) Therapeutics - Products under Investigation by Universities/Institutes
- Companies Involved in Type 1 Diabetes (Juvenile Diabetes) Therapeutics Development
- Type 1 Diabetes (Juvenile Diabetes) - Therapeutics Assessment
- Assessment by Monotherapy Products
- Assessment by Combination Products
- Assessment by Route of Administration
- Assessment by Molecule Type
- Drug Profiles
- Type 1 Diabetes (Juvenile Diabetes) Therapeutics - Drug Profile Updates
- Type 1 Diabetes (Juvenile Diabetes) Therapeutics - Discontinued Products
- Type 1 Diabetes (Juvenile Diabetes) Therapeutics - Dormant Products
- Type 1 Diabetes (Juvenile Diabetes) - Product Development Milestones
- Featured News & Press Releases
- Appendix
For more information visit http://www.researchandmarkets.com/research/31e837/type_1_diabetes_j